We are live on ! Find out more
DCM

DAFNA Capital Management Portfolio holdings

AUM $440M
1-Year Est. Return 109.12%
This Fund
S&P 500
This Quarter Est. Return
+35.64%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$291M
AUM Growth
+$25.4M
Cap. Flow
-$37.9M
Cap. Flow %
-13.02%
Top 10 Hldgs %
53.99%
Holding
96
New
7
Increased
8
Reduced
27
Closed
15

Top Buys

1
PRQR icon
ProQR Therapeutics
PRQR
+$6.64M
2
AFMD
Affimed
AFMD
+$3.03M
3
STIM icon
Neuronetics
STIM
+$1.8M
4
OTIC
Otonomy, Inc.
OTIC
+$1.15M
5
KURA icon
Kura Oncology
KURA
+$1.03M

Top Sells

1
ALDR
Alder Biopharmaceuticals
ALDR
+$12M
2
WVE icon
Wave Life Sciences
WVE
+$3.94M
3
ASND icon
Ascendis Pharma A/S
ASND
+$3.6M
4
APLS
Apellis Pharmaceuticals
APLS
+$3.57M
5
ARDX icon
Ardelyx
ARDX
+$2.31M

Sector Composition

1 Healthcare 91.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STXS icon
1
Stereotaxis
STXS
$161M
$72.4M 24.84%
13,680,554
– –
PRQR icon
2
ProQR Therapeutics
PRQR
$244M
$11M 3.79%
1,114,000
+852,479
+326% +$6.64M
ATRC icon
3
AtriCure
ATRC
$1.75B
$10.4M 3.56%
318,729
– –
ARQL
4
DELISTED
Arqule Inc
ARQL
$9.94M 3.41%
497,762
-32,500
-6% -$377K
BPMC
5
DELISTED
Blueprint Medicines
BPMC
$9.87M 3.39%
123,218
– –
LKFT
6
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
$9.72M 3.34%
47,000
-5,509
-10% -$1.02M
FATE icon
7
Fate Therapeutics
FATE
$350M
$9.2M 3.16%
470,000
– –
SAGE
8
DELISTED
Sage Therapeutics
SAGE
$9.01M 3.09%
124,806
– –
DXCM icon
9
DexCom
DXCM
$28.1B
$7.95M 2.73%
145,352
– –
IBB icon
10
iShares Biotechnology ETF
IBB
$9.23B
$7.82M 2.68%
64,900
– –
NBIX icon
11
Neurocrine Biosciences
NBIX
$17.2B
$6.56M 2.25%
61,008
-3,500
-5% -$366K
AERI
12
DELISTED
Aerie Pharmaceuticals
AERI
$6.47M 2.22%
267,839
-19,909
-7% -$412K
ZGNX
13
DELISTED
Zogenix, Inc.
ZGNX
$5.57M 1.91%
106,749
-36,015
-25% -$1.65M
TVRD
14
Tvardi Therapeutics
TVRD
$28.8M
$5.29M 1.82%
9,126
-1,400
-13% -$982K
AKBA icon
15
Akebia Therapeutics
AKBA
$370M
$4.87M 1.67%
770,538
-57,500
-7% -$273K
LMNX
16
DELISTED
Luminex Corp
LMNX
$4.73M 1.62%
204,091
– –
ARNA
17
DELISTED
Arena Pharmaceuticals Inc
ARNA
$4.49M 1.54%
98,942
+5,000
+5% +$236K
CYTK icon
18
Cytokinetics
CYTK
$11.2B
$4.44M 1.53%
418,727
– –
BHVN
19
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$4.07M 1.4%
74,700
-20,300
-21% -$1.01M
ASND icon
20
Ascendis Pharma A/S
ASND
$17.5B
$3.91M 1.34%
28,100
-32,380
-54% -$3.6M
VYNE icon
21
VYNE Therapeutics
VYNE
$25.5M
$3.7M 1.27%
11,077
-825
-7% -$275K
XENE icon
22
Xenon Pharmaceuticals
XENE
$6.53B
$3.26M 1.12%
248,854
-81,813
-25% -$861K
AFMD
23
DELISTED
Affimed
AFMD
$3.11M 1.07%
+113,356
New +$3.03M
ACHN
24
DELISTED
Achillion Pharmaceuticals
ACHN
$2.65M 0.91%
438,884
– –
DRNA
25
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2.61M 0.89%
118,314
– –
1
2 3 4

Similar funds

FGWP
Founders Grove Wealth Partners Richmond, Virginia $440M AUM 16.56% 1-Year Est. Return
STCG
Speece Thorson Capital Group Minnetonka, Minnesota $439M AUM 10.15% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
AWM
Austin Wealth Management Austin, Texas $440M AUM 17.66% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $440M AUM